HIV, Pediatrics, Tuberculosis
Conditions
Keywords
HIV, Tuberculosis, Diagnosis, Pediatrics, Asia, Africa
Brief summary
Childhood tuberculosis (TB) accounts for 11% of the total 9 million annual TB cases and the difficulty of its diagnosis is increased in case of HIV infection in children. The aim of this study is to improve TB diagnosis in HIV-infected children by developing a new diagnostic algorithm incorporating new tools available such as: * interferon gamma release assays (IGRAs), as alternative to the tuberculin skin test * alternative specimen collection methods such as string test (or Enterotest (R)), nasopharyngeal aspirates and stools samples, as alternatives to gastric aspirate * the Xpert MTB/RIF assay
Interventions
OTHERDevelopment of a diagnosis algorithm
At entry in the study, HIV infected children with suspected tuberculosis will undergo a complete evaluation including: * interview on anamnesis * clinical examination * evaluation of HIV infection stage * hematology and biochemistry tests * CD4 count * HIV viral load * IGRA * chest radiograph * Abdominal ultrasonograph to detect abdominal lymphadenopathy * Tuberculin skin test * gastric aspirates, sputum and string tests according to the age of children * nasopharyngeal aspirate * stool sample * lymph node fine needle aspirate or other specimen collection if applicable Diagnosis and treatment of all participating children will be done according to national guidelines. The children will be followed-up for 6 months until the end of their anti-TB treatment. For the analysis of data and the validation of the algorithm, children will be randomized into 2 groups. Data from Group I will be used to develop the algorithm; data from Group II will be used to validate it.
Sponsors
Institut Pasteur, Cambodia
National Pediatric Hospital, Cambodia
Angkor Hospital for Children
Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam
Number 2 Children's Hospital, Ho Chi Minh City
Hôpital Necker-Enfants Malades, Paris, France
Groupe Hospitalier Pitie-Salpetriere
CHRU Arnaud de Villeveuve, Montpellier, France
IRD, Yaounde, Cameroon
Fondation Chantal Biya,Yaounde, Cameroon
CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso
Centre Muraz
Centre Pasteur du Cameroun
Centre Hospitalier D'essos
ANRS, Emerging Infectious Diseases
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
No minimum to 13 Years
Healthy volunteers
No
Inclusion criteria
* children aged from 0 to 13 years * confirmed HIV infection * suspicion of tuberculosis * informed consent signed by at least one parent or guardian * on ARVs or not
Exclusion criteria
* history of anti TB treatment started in the past 2 years * on going tuberculosis treatment * Suspicion of exclusive extra-thoracic tuberculosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Tuberculosis diagnostic algorithm | 3 years | Development of an effective diagnostic algorithm for pediatric tuberculosis after evaluating the following diagnostic tests and sampling methods: * Clinical examination * Chest X-rays * Abdominal ultrasound * IGRAs * Xpert MTB/RIF * Gastric aspirate * String test * Nasopharyngeal aspirate * Stools sample * Sputum samples |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the QuantiFERON(R)-TB Gold In-Tube | 6 months | Evaluation of the sensitivity, specificity, positive and negative predictive values of an in-vitro Interferon Gamma Release (IGRAs) : the QuantiFERON(R)-TB Gold iIn-Tube, for the diagnosis of TB in HIV infected children |
| Percentage of TB diagnosis sampling procedures actually performed | 6 months | To assess the feasibility of the following TB sampling procedures: * the string test * the nasopharyngeal aspirate * stool sample |
| Evaluation of the morbidity (IRIS, drug toxicity and other opportunistic infections) and mortality in TB-HIV co-infected children | at 6 month of TB treatment | — |
| Comparison of two in-vitro IGRAs | 6 months | Comparison of the performances of two in-vitro IGRAs: the QauntiFERON(R)-TB Gold In-Tube and the T.SPOT-TB(R), for the diagnosis of tuberculosis in a sub-group of HIV infected children. |
| Evaluation of the Xpert MTB/RIF assay | 6 months | Evaluate the sensitivity, specificity, positive and negative predictive values of the Xpert MTB/RIF assay |
| Comparison of the Xpert MTB/RIF test to the gold standard (culture of gastric aspirates or sputum) | 6 months | — |
| Comparison of the performance Xpert MTB/RIF assay on sampling methods other than the reference method (gastric aspirate and sputum) | 6 months | Evaluation of the Xpert MTB/RIF assay on the following sampling methods: * String test * Nasopharyngeal aspirates * Stool samples |
| Specificity and sensibility of TB diagnosis sampling procedures compared to TB diagnosis gold standard (sputum or gastric aspirate culture) | 6 months | To assess the performance of the following TB sampling procedures: * the string test * the nasopharyngeal aspirate * stools sample |
Countries
Burkina Faso, Cambodia, Cameroon, Vietnam
Outcome results
None listed